53 results
DEFM14A
IMGN
Immunogen, Inc.
2 Jan 24
Proxy related to merger
4:26pm
OWNERS AND MANAGEMENT
FUTURE SHAREHOLDER PROPOSALS
OTHER MATTERS
WHERE YOU CAN FIND MORE INFORMATION
MISCELLANEOUS
ii
SUMMARY
This summary … , 2023, through the exercise of stock options.
FUTURE SHAREHOLDER PROPOSALS
If the Merger is completed, we will have no public ImmunoGen Shareholders
PREM14A
IMGN
Immunogen, Inc.
21 Dec 23
Preliminary proxy related to merger
4:52pm
AND MANAGEMENT
FUTURE SHAREHOLDER PROPOSALS
OTHER MATTERS
WHERE YOU CAN FIND MORE INFORMATION
MISCELLANEOUS
ii
SUMMARY
This summary highlights … executive officers in the aggregate within 60 days of December 15, 2023 through the exercise of stock options.
FUTURE SHAREHOLDER PROPOSALS
424B5
IMGN
Immunogen, Inc.
5 May 23
Prospectus supplement for primary offering
4:49pm
plan, or “poison pill,” which could have the effect of discouraging or delaying a takeover of the company.
Advance notice provisions for shareholder … proposals and shareholder nominations of directors. Our amended and restated by-laws provide that, for nominations to the board of directors
424B5
IMGN
Immunogen, Inc.
3 May 23
Prospectus supplement for primary offering
4:05pm
,” which could have the effect of discouraging or delaying a takeover of the company.
Advance notice provisions for shareholder proposals and shareholder
424B5
zeyh98s4g9i7k3z
3 Dec 21
Prospectus supplement for primary offering
4:06pm
424B5
j7wu06jac4 59r8z
30 Nov 21
Prospectus supplement for primary offering
5:12pm
424B5
z86o7f coqsk9u2
12 Aug 21
Prospectus supplement for primary offering
10:11am
424B5
5mxfhcu c10lex
18 Dec 20
Prospectus supplement for primary offering
5:16pm
S-3ASR
iu8 eu6cp
18 Dec 20
Automatic shelf registration
4:45pm
424B5
tlbcgdoi
25 Sep 20
Prospectus supplement for primary offering
4:23pm
424B5
i1zi1 gngi9xia
23 Jan 20
Prospectus supplement for primary offering
4:05pm
424B5
rd29p9bc
22 Jan 20
Prospectus supplement for primary offering
4:07pm